![]() |
市場調查報告書
商品編碼
1618264
下垂腳治療設備:市場洞察·競爭環境·市場預測 (~2030年)Foot Drop Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
在 2024 年至 2030 年的預測期內,足下垂治療設備市場規模預計將以 8.15% 的複合年增長率成長。
由於包括多發性硬化症在內的慢性神經系統疾病盛行率上升、下肢疼痛病例數量增加以及人口老化等因素,足下垂治療設備市場呈現出顯著的市場成長。
足下垂治療設備:市場動態
根據世界衛生組織資料(2023 年),據報導全球有超過 180 萬人患有多發性硬化症。此疾病影響多種功能,包括認知、情緒、運動、感覺和視覺能力。當免疫系統錯誤地攻擊大腦和脊髓時,就會發生多發性硬化症。多發性硬化症的增加是足下垂治療設備需求的主要驅動力,因為多發性硬化症通常會導致運動障礙,包括足部下垂。多發性硬化症會損害運動功能和獨立性,需要先進的解決方案,例如功能性電刺激器來恢復行走。
根據世界衛生組織2021年發布的數據,2015年至2050年間,60歲及以上老年人跌倒的比例將從12%翻倍至22%,到2050年,全球將有21億人遭受跌倒之苦。此外,到 2030 年,六分之一的人將年齡在 60 歲或以上。世界人口老化增加了中風、週邊神經病變和退化性疾病等與年齡相關的疾病的盛行率,這些都是導致足下垂的主要原因。因此,對治療設備的需求不斷增長,以提高老年人的運動能力和改善生活品質。
依產品類型劃分,電刺激設備細分市場在 2023 年將佔據顯著的收入佔有率。這是因為它的非侵入性、恢復功能性運動的能力以及重新訓練肌肉的有效性。
這些設備採用先進的功能性電刺激技術來激活背屈肌,改善步態並降低跌倒風險。便攜性、客製化選項和可穿戴設計使其適合日常使用。此外,人們越來越認識到其在中風和多發性硬化症等神經系統疾病的康復和治療中的應用,也支持了該產品的廣泛使用。
本報告提供全球下垂腳治療設備的市場調查,彙整市場概要,市場影響因素及市場機會分析,法律制度,市場規模的轉變·預測,各種區分·地區/各主要國家的詳細分析,競爭情形,主要企業簡介等資訊。
Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of chronic neurological disorders and the growing cases of lower limb pain worldwide
The foot drop treatment devices market is projected to grow at a CAGR of 8.15% during the forecast period from 2024 to 2030. The foot drop treatment devices market is observing substantial market growth primarily owing to the rising prevalence of chronic neurological disorders including multiple sclerosis, growing cases of lower limb pain, and the rising geriatric population that are expected to escalate the overall growth of the foot drop treatment devices market during the forecast period from 2024 to 2030.
Foot Drop Treatment Devices Market Dynamics:
As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by multiple sclerosis. It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and the spinal cord. The prevalence of multiple sclerosis significantly drives the demand for foot drop treatment devices, as multiple sclerosis often leads to motor impairments, including foot drop. The condition disrupts mobility and independence, requiring advanced solutions like functional electrical stimulators to restore gait.
As per data provided by the WHO 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. The aging global population increases the prevalence of age-related conditions like stroke, peripheral neuropathy, and degenerative disorders, which are major causes of foot drop. This drives the demand for treatment devices to enhance mobility and improve the quality of life in elderly individuals.
Therefore, all the factors stated above collectively will drive the overall foot drop treatment devices market growth.
However, the side effects associated with prolonged usage, fitting-related issues, and others may prove to be challenging factors for the foot drop treatment devices market growth during the forecast period.
Foot Drop Treatment Devices Market Segment Analysis:
Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the foot drop treatment devices, the electrical stimulator category is expected to have a significant revenue share in the year 2023. This is due to their non-invasive nature, ability to restore functional movement, and effectiveness in re-educating muscles.
These devices use advanced functional electrical stimulation technology to activate dorsiflexor muscles, improving gait and reducing the risk of falls. Their portability, customization options, and compatibility with wearable designs make them convenient for daily use. Additionally, the increasing awareness about their therapeutic benefits and their application in rehabilitation for neurological conditions like stroke and multiple sclerosis is further expected to drive their adoption.
Therefore, the widespread uses and key features of electrical stimulators that enhance their performance are solidifying the impact on the growth of the overall foot drop treatment devices market, during the forecast period from 2024 to 2030.
North America is expected to dominate the overall foot drop treatment devices market:
Among all the regions, North America is expected to dominate the foot drop treatment devices market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of guillain-barre syndrome, increasing cases of lower limb pain combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure; acting as key factors contributing to the growth of the foot drop treatment devices market in the North America region during the forecast period from 2024 to 2030.
According to data from the Centers of Disease Control and Prevention (2023), it was stated that guillain-barre syndrome is a rare disorder in which the body's immune system mistakenly attacks the peripheral nerves. This damage to the nerves leads to muscle weakness and, in some cases, paralysis. In the United States, an estimated 3,000 to 6,000 people develop guillain-barre syndrome each year. Thus the rising cases of guillain-barre syndrome is increasing demand for foot drop treatment devices as guillain-barre syndrome often causes nerve damage leading to muscle weakness and foot drop.
Further, the Centre for Disease Control and Prevention (2021), stated that the percentage of adults experiencing lower limb pain rose with age, starting at 21.0% for individuals aged 18-29, increasing to 28.8% for those aged 30-44, 43.4% for adults aged 45-64, and reaching 50.3% for those aged 65 and over. The increasing prevalence of lower limb pain with age is driving the demand for foot drop treatment devices. As more individuals experience knee issues or age-related pain, the likelihood of developing foot drop increases, creating a larger patient base for assistive devices to improve mobility and quality of life.
Additionally, the prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional foot drop treatment devices market growth. The presence of key players with their strong distribution networks ensures widespread availability and accessibility of these devices across the region, thus increasing their revenue shares in the market, along with supportive reimbursement programs providing immense growth opportunities for the same.
Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American foot drop treatment devices market.
Foot Drop Treatment Devices Market key players:
Some of the key market players operating in the foot drop treatment devices market include Ottobock, Bioness Inc, AxioBionics, Saebo, Inc., OrthoPediatrics Corp., Turbomed Orthotics, Ossur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Arthrex, Inc., Evolution Devices, Narang Medical Limited, AliMed, Cionic, and others.
Recent Developmental Activities in the Foot Drop Treatment Devices Market:
Key Takeaways from the Foot Drop Treatment Devices Market Report Study
Target Audience who can be benefited from this Foot Drop Treatment Devices Market Report Study
Frequently Asked Questions for the Foot Drop Treatment Devices Market: